logo

Anchoring Your Portfolio: Is ARWR Stock a Safe Harbor?

Arrowhead Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $30.41 on 07/16/24 and the lowest value was $9.57 on 04/07/25.

52-week price history of ARWR Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Arrowhead Pharmaceuticals Inc’s current trading price is -62.74% away from its 52-week high, while its distance from the 52-week low is 18.39%. The stock’s price range during this period has spanned from $9.57 to $30.41. In the Healthcare sector, the Arrowhead Pharmaceuticals Inc’s shares surpassed a trading volume of approximately 1.06 million for the day, which was noticeably lower compared to the average daily volume of 9.2.05 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Arrowhead Pharmaceuticals Inc (ARWR) has experienced a quarterly decline of -40.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.56B and boasts a workforce of 609 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 18.32, with a change in price of -7.29. Similarly, Arrowhead Pharmaceuticals Inc recorded 1,955,869 in trading volume during the last 100 days, posting a change of -39.19%.

Examining ARWR’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ARWR stands at 16.58. Similarly, the long-term debt-to-equity ratio is also 16.43.

ARWR Stock Stochastic Average

Today, Arrowhead Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 14.18%, indicating a decline from the raw stochastic average of the last 20 days, which was 28.29%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 42.33% and 40.64% respectively.

ARWR Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -39.73%.However, over the last six months, we can see a stronger performance of -41.48%. Over the last 30 days, the price of ARWR has leaped by -24.94%. And in the last five days, it has fallen by -3.98%.

Most Popular